Novo Nordisk cuts Wegovy price by up to 37% in India

By Rishika Sadam BENGALURU (Reuters) -Danish drugmaker Novo Nordisk said on Tuesday it had cut the price of its weight-loss ...

Novo Nordisk: Hold On Tightly As The Market Tests Your Faith

Novo Nordisk navigates competition and guidance challenges with strong profitability and upcoming oral Wegovy opportunities.

Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk

Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war ...

Exclusive: Novo Nordisk cuts Wegovy price by up to 33% in India, document shows

Danish drugmaker Novo Nordisk on Tuesday cut the price of its blockbuster weight-loss drug, Wegovy, by up to 33% in India, ...

Novo Nordisk: Consider The Counterfactual

Novo Nordisk's softening sales performance, which prompted restructuring, has resulted in significantly reduced profit ...
Fierce Biotech

Novo Nordisk shares mixed data behind pivotal heart disease push

Novo Nordisk has reported the mixed midphase results behind its push to enter a heart disease market s | Novo Nordisk has reported the mixed midphase results behind its push to enter a heart disease ...

Novo Nordisk, Emcure to launch weight-loss drug under new brand in India

Novo Nordisk has partnered with India's Emcure Pharmaceuticals to exclusively distribute and market its weight-loss drug ...

What’s Next for Novo Nordisk?

After [losing out to Pfizer]( ...
Devdiscourse

Novo Nordisk Slashes Wegovy Prices in India Amidst Intense Market Competition

Novo Nordisk has cut prices of its weight-loss drug Wegovy by up to 37% in India. This move intensifies competition with Eli ...

Eli Lilly stock soars to new highs, Novo Nordisk lags. Here's why.

Eli Lilly (LLY) stock is trading at record highs after the pharmaceutical company reached a deal with the White House to ...